AUSTIN, TX, Nuclein has closed a $14 million Series B funding round, led by Trinity Private Equity Group
Nuclein has closed a $14 million Series B funding round, led by Trinity Private Equity Group (TPEG), a Southlake, Texas-based private equity firm.
Nuclein, LLC was founded in 2017 by long-time Austin biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's vision is to enable simple, affordable, rapid, and accurate disease testing for everyone.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
